Page last updated: 2024-09-05

lu 135252 and Hypertriglyceridemia

lu 135252 has been researched along with Hypertriglyceridemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ezra, D; Ezra-Nimni, O; Munter, K; Peleg, E; Rosenthal, T	1

Other Studies

1 other study(ies) available for lu 135252 and Hypertriglyceridemia

Article	Year
Trandolapril and endothelin antagonist LU-135252 in the treatment of the fructose-induced hypertensive, hyperinsulinemic, hypertriglyceridemic rat. American journal of hypertension, 2003, Volume: 16, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Synergism; Endothelin Receptor Antagonists; Fructose; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Indoles; Insulin; Male; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Time Factors; Triglycerides	2003

Article

Year

Trandolapril and endothelin antagonist LU-135252 in the treatment of the fructose-induced hypertensive, hyperinsulinemic, hypertriglyceridemic rat.

American journal of hypertension, 2003, Volume: 16, Issue:4

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Synergism; Endothelin Receptor Antagonists; Fructose; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Indoles; Insulin; Male; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Time Factors; Triglycerides

2003